Up about 12%, Tempus AI (NASDAQ:TEM) has been explosive. Helping, its volume just spiked to 18.6 million shares, as compared ...

We recently compiled a list of the 10 Companies Jump on Better Earnings, Outlook. In this article, we are going to take a ...

TD Cowen analyst Dan Brennan reinstated coverage of Tempus AI (TEM) with a Buy rating and price target of $74, up from $58, following the ...

AI stocks are red-hot today. Last night Alphabet (Nasdaq: GOOGL) reported earnings and its stock is down 8% today. That ...

Coming to the latest development around Olivia, the investors are optimistic, evident from the stock surge last week.

However, growth projections for Tempus AI’s legacy business are slightly below market consensus. Given these mixed signals – strong core business growth but with some revenue softness and ...

Given that Tempus AI has AI in its name, as you'd expect, the business deploys AI to improve the accuracy of their results, while delivering more personalized data-driven insights. They argue that ...

Tempus AI is a technology company that aims to advance precision medicine by applying AI to healthcare. The company went public in 2024, but shares have traded lower since its public debut.